Indo US Bio-Tech Ltd

NSE: INDOUS · BSE: 541304 · Food, Beverages & Tobacco · 30 announcements

Share price: ₹65.33
Market cap: ₹131.0 Cr
Revenue (annual): ₹110.4 Cr
Net profit (annual): ₹13.12 Cr
P/E (TTM): 30.2×Sector 29.0×
Promoter holding: 68.29%+0.00% QoQ
FII holding: 0.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Board Meeting Outcome 4 Annual General Meeting 4 Other Announcement 3 Board Meeting Date 3 Management Change 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

30 Oct 2026 16:12 IST BSE

Financial Results

Indo US Bio-Tech Q2 FY27 Results: Net Loss of ₹3.7 Cr

Indo US Bio-Tech Ltd reported revenue from operations of ₹15 Cr (-51.3% YoY) and a net loss of ₹3.7 Cr for Q2 FY27.

Key figure: Net loss ₹3.7 Cr

Open full results → Read the filing ↗

12 Aug 2026 15:24 IST BSE

Financial Results

Indo US Bio-Tech Q1 FY27 Results: Net Profit ₹3 Cr, Down 36.2% YoY

Indo US Bio-Tech Ltd reported revenue from operations of ₹33 Cr (+7.1% YoY) and net profit of ₹3 Cr (-36.2% YoY) for Q1 FY27.

Key figure: Net profit ₹3 Cr · -36.2% YoY

Open full results → Read the filing ↗

29 May 2026 18:20 IST NSE

Financial Results

Indo US Bio-Tech Q4 FY26 Results: Net Profit ₹2 Cr, Down 45.9% YoY

Indo US Bio-Tech Ltd reported revenue from operations of ₹26 Cr (-22.2% YoY) and net profit of ₹2 Cr (-45.9% YoY) for Q4 FY26.

Key figure: Net profit ₹2 Cr · -45.9% YoY

Open full results → Read the filing ↗

29 May 2026 18:19 IST NSE

Financial Results

Indo US Bio-Tech Financial Results

Indo Us Biotech Limited reported audited financial results for the year ended March 31, 2026. Revenue from operations reached ₹110.44 Crore, marking steady growth.

Open announcement → Read the filing ↗